InspireMD, Inc. NSPR

Company Overview

InspireMD, Inc. (NASDAQ: NSPR) is a medical device company focused on the development and commercialization of technologies for the treatment of vascular and coronary disease. The company operates within the cardiovascular medical technology industry, with a primary emphasis on carotid artery disease and stroke prevention. InspireMD is best known for its proprietary MicroNet mesh technology, which is integrated into its carotid stent platform to reduce the risk of embolic events during carotid artery procedures. Its principal commercial product platform is the CGuard carotid embolic prevention system, designed for carotid artery stenting procedures intended to treat carotid artery stenosis.

The company’s revenue model is primarily driven by sales of carotid stent systems and related vascular products in international markets while it pursues broader regulatory approvals, including in the United States. InspireMD historically focused on coronary and peripheral vascular technologies before narrowing its strategic focus toward neurovascular and carotid intervention applications. The company has positioned itself around differentiated embolic protection technology intended to improve procedural safety and clinical outcomes compared with conventional carotid stents. Public disclosures, including SEC filings and clinical communications, indicate that the company’s strategy centers on leveraging clinical evidence and regulatory milestones to expand physician adoption and commercial penetration.